Chronic prostatitis (CP) is a common genitourinary disorder in adult men. It has a high incidence, a complex disease, and a lingering course, which seriously affects the quality of life of patients. For the treatment of CP, the currently available treatment methods are limited and patients are not satisfied with the treatment results. Therefore, more effective treatment options need to be further explored.
The study is a single-blind, parallel-group, randomized controlled clinical trial consisting of a 4-to-6-week treatment period and a 6-month follow-up period. Included participants will be randomized into three groups and given a treatment regimen of acupuncture, qianliean suppository, respectively. Patients in each group will be treated for 1 month as a course of treatment. The clinical efficacy and changes in inflammatory factor levels in each group will be assessed at the end of treatment.
The trial aims to promote a more effective, standardized, and efficacious treatment protocol for CP in the clinical setting.
Medicine. 2021 Dec 23 [Epub]
Yi Lei, Hong-Hong Du
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, P. R. China., The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, P. R. China.